Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Pulmicort

23andMe launches personal genome service in the UK

Mail-order genetic service will cost £125

- PMLiVE

AZ and Cancer Research UK to collaborate on new medicines

Charity’s scientists to be given access to pharma company’s molecule library

- PMLiVE

Amgen/AZ confirm brodalumab psoriasis filing in 2015

Drug demonstrates greater effectiveness than J&J’s Stelara

- PMLiVE

AZ’s new COPD therapy gets green light in Europe

EC backs Duaklir in chronic respiratory condition

- PMLiVE

AZ seeks leg up in antiplatelet market with Brilinta antidote

Reversal agent has been developed by company's biotech subsidiary Medimmune

- PMLiVE

Life sciences minister: Go digital for NHS savings

Greater use of health technology could free funds for drug spending, says George Freeman

UK unveils digital health strategy

Plans greater use of mobile technology and will track NHS 'digital health maturity'

Novo taps behavioural change for diabetes programme’s re-launch

Adds health coach function to Cornerstones4Care

European Commission forms €2.5bn big data partnership

Says mastering data will lead to better health outcomes

- PMLiVE

Integrating digital: developing a social conference

Boehringer Ingelheim’s director of oncology Albert van Eijk on the digital elements of its multichannel efforts

- PMLiVE

Nexium windfall lifts AZ in third quarter

Still to feel effects of generic competition

- PMLiVE

GSK first to file IL-5 antagonist for asthma

Mepolizumab submitted as a treatment for severe eosinophilic asthma

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links